2m 2m 2m 2m 2m 2m 2m
Johnson&Johnson (JNJ)
NYSE
$257.50+$0.52 (+0.20%)
Price as of Jul 13, 2026 5:01 PM EDT- $618.6BMarket Cap
- 67.88%1-Year Change
- Drug Manufacturers - GeneralIndustry
Johnson&Johnson (JNJ)
$257.50+$0.52 (+0.20%)
JNJ | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $256.98 | ||
Change | -$2.12 (-0.82%) | ||
Open | $260.19 | ||
High | $261.30 | ||
Low | $255.52 | ||
Previous Close | $259.10 | ||
Volume | 6,540,030 | ||
30-Day Average Volume | 8,924,741 | ||
1-Week Change | -2.30% | ||
1-Month Change | 7.75% | ||
1-Year Change | 67.88% | ||
3-Year Change | 75.85% | ||
5-Year Change | 74.25% | ||
Fundamentals | |||
Shares Outstanding | 2.4B | ||
Total Assets | $200.9B | ||
Market Cap | $618.6B | ||
Enterprise Value | $651.9B | ||
Period: QTR TTM FY | |||
Revenue | $24.1B | ||
Net Income | $5.2B | ||
Free Cash Flow | $1.5B | ||
EBIT | $6.0B | ||
EBITDA | $8.0B | ||
Net Working Capital | $1.5B | ||
EPS | $2.14 | ||
Enterprise Value/EBITDA | 82 | ||
Enterprise Value/Revenue | 27 | ||
P/B | 8 | ||
P/E | 120 | ||
PEG | 52 | ||
Price/Free Cash Flow | 422 | ||
Price/Operating Cash Flow | 246 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.09% | ||
Trailing Annual Dividend Yield | 2.04% | ||
Ex-Dividend Date | 05/26/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield